Close Menu

Biotech company Geron, long known for its pioneering research on stem cells, has announced that it will no longer conduct such research, reports New Scientist's Andy Coghlan. Geron's stem cell program was the largest in the world, and currently runs trials to treat various disorders and diseases with stem cell therapies, including one to treat people with spinal injuries, Coghlan says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.